DK1259474T3 - Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf - Google Patents

Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf

Info

Publication number
DK1259474T3
DK1259474T3 DK01900037T DK01900037T DK1259474T3 DK 1259474 T3 DK1259474 T3 DK 1259474T3 DK 01900037 T DK01900037 T DK 01900037T DK 01900037 T DK01900037 T DK 01900037T DK 1259474 T3 DK1259474 T3 DK 1259474T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
ethers
calcium dicarboxylate
calcium
Prior art date
Application number
DK01900037T
Other languages
English (en)
Inventor
Howard Yoshihisa Ando
Donald Eugene Butler
Gary Jay Dozeman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1259474T3 publication Critical patent/DK1259474T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK01900037T 2000-01-25 2001-01-11 Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf DK1259474T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25
PCT/IB2001/000026 WO2001055078A1 (en) 2000-01-25 2001-01-11 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith

Publications (1)

Publication Number Publication Date
DK1259474T3 true DK1259474T3 (da) 2009-07-20

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01900037T DK1259474T3 (da) 2000-01-25 2001-01-11 Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf

Country Status (39)

Country Link
EP (1) EP1259474B1 (da)
JP (1) JP4750995B2 (da)
KR (1) KR20020073182A (da)
CN (1) CN1395555A (da)
AP (1) AP2002002587A0 (da)
AR (1) AR029436A1 (da)
AT (1) ATE431326T1 (da)
AU (1) AU2214001A (da)
BG (1) BG106851A (da)
BR (1) BR0107763A (da)
CA (1) CA2397960C (da)
CO (1) CO5261537A1 (da)
CZ (1) CZ20022474A3 (da)
DE (1) DE60138686D1 (da)
DK (1) DK1259474T3 (da)
DZ (1) DZ3239A1 (da)
EA (1) EA004862B1 (da)
EE (1) EE200200404A (da)
ES (1) ES2324281T3 (da)
GE (1) GEP20053428B (da)
GT (1) GT200100015A (da)
HN (1) HN2001000011A (da)
HU (1) HUP0204422A3 (da)
IL (1) IL150541A0 (da)
IS (1) IS6442A (da)
MA (1) MA26867A1 (da)
MX (1) MXPA02007223A (da)
NO (1) NO20023526L (da)
NZ (1) NZ519550A (da)
OA (1) OA12166A (da)
PA (1) PA8510601A1 (da)
PE (1) PE20011064A1 (da)
PL (1) PL357076A1 (da)
SK (1) SK10622002A3 (da)
SV (1) SV2002000290A (da)
TN (1) TNSN01013A1 (da)
UY (1) UY26550A1 (da)
WO (1) WO2001055078A1 (da)
ZA (1) ZA200205880B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
PL375742A1 (en) * 2002-08-22 2005-12-12 Warner-Lambert Company Llc Method of treating osteoarthritis
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
EP1873141A4 (en) * 2005-04-19 2010-09-22 Eisai R&D Man Co Ltd CALCIUM-BIS [2S] -3- [3- (2S) -3- (4-CHLORO-2-CYANOPHENOXY) -2-FLUORO-PROPOXYPHENYL] -2-ISOPROPOXYPROPIONATE] AND INTERMEDIATE PRODUCTS THEREOF
AU2015346037A1 (en) * 2014-11-14 2017-07-06 Gemphire Therapeutics Inc. Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers
CN110996928A (zh) * 2017-04-18 2020-04-10 燿石治疗公司 吉卡宾、其药学上可接受的盐、其组合物和其使用方法
US20200253877A1 (en) * 2018-10-18 2020-08-13 Neurobo Pharmaceuticals, Inc. Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
PE20011064A1 (es) 2001-10-22
IS6442A (is) 2002-06-25
NO20023526L (no) 2002-08-27
SK10622002A3 (sk) 2003-07-01
ZA200205880B (en) 2003-07-23
OA12166A (en) 2003-11-07
CA2397960A1 (en) 2001-08-02
DE60138686D1 (de) 2009-06-25
MA26867A1 (fr) 2004-12-20
KR20020073182A (ko) 2002-09-19
EA200200641A1 (ru) 2002-12-26
AP2002002587A0 (en) 2002-09-30
MXPA02007223A (es) 2002-11-29
CA2397960C (en) 2008-09-09
JP2003520835A (ja) 2003-07-08
CN1395555A (zh) 2003-02-05
AU2214001A (en) 2001-08-07
EA004862B1 (ru) 2004-08-26
NO20023526D0 (no) 2002-07-24
PA8510601A1 (es) 2002-08-26
EP1259474A1 (en) 2002-11-27
HUP0204422A2 (en) 2003-05-28
EE200200404A (et) 2003-10-15
DZ3239A1 (fr) 2001-08-02
BG106851A (en) 2003-01-31
CZ20022474A3 (cs) 2003-06-18
WO2001055078A1 (en) 2001-08-02
GT200100015A (es) 2001-10-19
AR029436A1 (es) 2003-06-25
HUP0204422A3 (en) 2003-08-28
JP4750995B2 (ja) 2011-08-17
NZ519550A (en) 2003-11-28
ATE431326T1 (de) 2009-05-15
UY26550A1 (es) 2001-08-27
EP1259474B1 (en) 2009-05-13
ES2324281T3 (es) 2009-08-04
IL150541A0 (en) 2003-02-12
BR0107763A (pt) 2002-11-12
CO5261537A1 (es) 2003-03-31
TNSN01013A1 (fr) 2005-11-10
SV2002000290A (es) 2002-07-16
PL357076A1 (en) 2004-07-12
GEP20053428B (en) 2005-01-25
HN2001000011A (es) 2001-06-13

Similar Documents

Publication Publication Date Title
NL1017075A1 (nl) Preparaat.
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
GC0000227A (en) Permeable cements
GB2379927B (en) Permeable cements
DE69923594D1 (de) Flammhemmende, mikroporöse materialien
DE60128533D1 (de) Hebelschere
DK1309581T3 (da) Fremgangsmåde til fremstilling af citalopram
MXPA03001425A (es) Compuestos farmaceuticos.
BR0205277B1 (pt) cortador manual de cerámica.
DK1193010T3 (da) Vendeplatte til drejning
DK1147712T3 (da) Fremgangsmåde til fremstilling af en mælkecalcium-sammensætning
DK1259474T3 (da) Calcium-dicarboxylatethere, fremgangsmåder til fremstilling deraf
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DE50110340D1 (de) Splittergefechtskopf zur bekämpfung technischer ziele
IT1319686B1 (it) Procedimento di preparazione di citalopram.
ITTO20020747A1 (it) Composizione.
NO20024502L (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
IT1317851B1 (it) Procedimento di preparazione di miscele cementizie.
ITTO20020745A1 (it) Composizione.
DK1313481T3 (da) Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser
ES1050470Y (es) Bloque de hormigon.
IT1318672B1 (it) Procedimento per ottenere eteri fluorosolfonici.
ES1050514Y (es) Moldeadora de hormigon para cunetas.
IT1319677B1 (it) Composizione funghicida.
ITMI20010456V0 (it) Mescolatore per calcestruzzo.